Rocket Pharmaceuticals Issues Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I

  • Jonathan Schwartz,

Press/Media

Period30 Oct 2021

Media coverage

1

Media coverage

  • TitleRocket Pharmaceuticals Issues Positive Clinical Data from RP-L201 Trial for the Treatment of LAD-I
    Media name/outletWireless News(Close-up Media)
    Country/TerritoryUnited States
    Date30/10/21
    PersonsJonathan Schwartz,